Statement Of Changes In Equity [Abstract]

ERYTECH Pharma S.A. - Filing #858938

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Increase (decrease) through appropriation of retained earnings, equity
5 154 EUR
53 797 EUR
EUR
48 643 EUR
73 300 EUR
71 037 EUR
2 263 EUR
EUR
EUR
54 208 EUR
62 659 EUR
8 451 EUR
Increase (decrease) through conversion of convertible instruments, equity
14 400 EUR
Share issue related cost
3 811 EUR
3 811 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.